Nom du produit:4-Isopropyl-1H-pyrazol-3-amine

IUPAC Name:4-(propan-2-yl)-1H-pyrazol-5-amine

CAS:151521-49-2
Formule moléculaire:C6H11N3
Pureté:95%+
Numéro de catalogue:CM188981
Poids moléculaire:125.18

Unité d'emballage Stock disponible Prix($) Quantité
CM188981-1g in stock ǠȤ
CM188981-5g in stock ƩşƏ
CM188981-25g in stock ƅƅǺş

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:151521-49-2
Formule moléculaire:C6H11N3
Point de fusion:-
Code SMILES:NC1=C(C(C)C)C=NN1
Densité:
Numéro de catalogue:CM188981
Poids moléculaire:125.18
Point d'ébullition:295.8°C at 760 mmHg
N° Mdl:MFCD11112127
Stockage:Store at 2-8°C.

Category Infos

Pyrazoles
Pyrazoles are organic compounds of the general formula C3H3N2H. It is a five-membered heterocycle consisting of three carbon atoms and two adjacent nitrogen atoms. As an H-bond-donating heterocycle, pyrazole has been used as a more lipophilic and metabolically more stable bioisomer of phenol. Pyrazoles have attracted more and more attention due to their broad spectrum of action and strong efficacy.
Pyrazone
Custom pyrazone for customers from all over the world are our main business.

Column Infos

Samuraciclib
Carrick Therapeutics’ Phase 2 Clinical Trial of Samuraciclib combined with Fulvestrant has dosed its first patient. The study targets patients with CDK4/6i resistant HR+, HER2- metastatic breast cancer. Samuraciclib is a selective oral, first-in-class inhibitor of CDK7. It is involved in the regulation of cancer-causing genes, promotion of uncontrolled cell cycle progression, and increase in resistance to anti-hormone therapy. The comb previously receives the Fast Track Designation from the U.S. FDA.